Osteoporosis, Postmenopausal

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Gainesville, Georgia, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Urbandale, Iowa, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Billings, Montana, United States
• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Cincinnati, Ohio, United States

• Sanofi-Aventis — Bridgewater, New Jersey, United States
• Sanofi-Aventis — San Isidro, Argentina
• Sanofi-Aventis — Macquarie Park, Australia
• Sanofi-Aventis — Laval, Canada

• Sanofi-Aventis — Helsinki, Finland
• Sanofi-Aventis — Gouda, Netherlands
• Sanofi-Aventis — Oslo, Norway
• Sanofi-Aventis — Madrid, Spain

Not specified

• Kantou, Japan

Not specified

• Sanofi-Aventis Administrative Office — Bridgewater, New Jersey, United States

• Centre for Muscle and Bone Research, Charité - Campus Benjamin Franklin — Berlin, Germany

• Jerry L. Pettis Memorial Veterans Medical Center — Loma Linda, California, United States

• Novartis Investigative site — Basel, Switzerland